Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with <i>IL1A</i> and <i>TNFSF10</i>

Bridget Charbonneau,Matthew S. Block,William R. Bamlet,Robert A. Vierkant,Kimberly R. Kalli,Zachary Fogarty,David N. Rider,Thomas A. Sellers,Shelley S. Tworoger,Elizabeth Poole,Harvey A. Risch,Helga B. Salvesen,Lambertus A. Kiemeney,Laura Baglietto,Graham G. Giles,Gianluca Severi,Britton Trabert,Nicolas Wentzensen,Georgia Chenevix-Trench,Alice S. Whittemore,Weiva Sieh,Jenny Chang-Claude,Elisa V. Bandera,Irene Orlow,Kathryn Terry,Marc T. Goodman,Pamela J. Thompson,Linda S. Cook,Mary Anne Rossing,Roberta B. Ness,Steven A. Narod,Jolanta Kupryjanczyk,Karen Lu,Ralf Butzow,Thilo Dörk,Tanja Pejovic,Ian Campbell,Nhu D. Le,Clareann H. Bunker,Natalia Bogdanova,Ingo B. Runnebaum,Diana Eccles,James Paul,Anna H. Wu,Simon A. Gayther,Estrid Hogdall,Florian Heitz, Stanley B. Kaye,Beth Y. Karlan,Hoda Anton-Culver,Jacek Gronwald,Claus K. Hogdall,Diether Lambrechts,Peter A. Fasching,Usha Menon,Joellen Schildkraut,Celeste Leigh Pearce,Douglas A. Levine,Susanne Kruger Kjaer,Daniel Cramer,James M. Flanagan,Catherine M. Phelan,Robert Brown,Leon F.A.G. Massuger,Honglin Song,Jennifer A. Doherty,Camilla Krakstad,Dong Liang,Kunle Odunsi,Andrew Berchuck,Allan Jensen,Jan Lubiński,Heli Nevanlinna, Yukie T. Bean,Galina Lurie,Argyrios Ziogas,Christine Walsh,Evelyn Despierre,Louise Brinton,Alexander Hein,Anja Rudolph,Agnieszka Dansonka-Mieszkowska,Sara H. Olson,Philipp Harter,Jonathan Tyrer,Allison F. Vitonis,Angela Brooks-Wilson,Katja K. Aben,Malcolm C. Pike,Susan J. Ramus,Elisabeth Wik,Cezary Cybulski,Jie Lin, Lara Sucheston,Robert Edwards,Valerie McGuire,Jenny Lester,Andreas du Bois,Lene Lundvall,Shan Wang-Gohrke, Lukasz M. Szafron, Sandrina Lambrechts,Hannah Yang,Matthias W. Beckmann, Liisa M. Pelttari, Anne M. Van Altena,David van den Berg, Mari K. Halle,Aleksandra Gentry-Maharaj, Ira Schwaab, Urmila Chandran, Janusz Menkiszak,Arif B. Ekici, Lynne R. Wilkens,Arto Leminen,Francesmary Modugno, Grace Friel, Joseph H. Rothstein,Ignace Vergote,Montserrat Garcia-Closas,Michelle A.T. Hildebrandt, Piotr Sobiczewski,Linda E. Kelemen, Paul D.P. Pharoah, Kirsten Moysich,Keith L. Knutson,Julie M. Cunningham,Brooke L. Fridley,Ellen L. Goode

crossref(2023)

引用 0|浏览115
暂无评分
摘要

PDF file - 145K, Supplementary Table 1. Studies in the Ovarian Cancer Association Consortium (OCAC) are listed, as well as the abbreviation, location, type, and number of cases and controls for each study. Supplementary Table 2. The number of cases included in the analysis from each OCAC study site is listed by histologic subtype. Supplementary Table 3. Gene symbols and IDs are listed for NF-κB pathway genes that were tagged in this study, as well as chromosome position, number of SNPs tagged, and bin coverage of each gene using Hapmap or 1000 genomes as a reference. Supplementary Table 4. Reasons and numbers of samples excluded from the analysis following the sample quality control are described. Supplementary Table 5. We evaluated rs17561 and rs6785617 for interactions with known epidemiologic risk factors for risk of clear cell and LMP tumors, respectively, and report interaction p-values in the table below.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要